Catalent Expands OptiMelt® Hot Melt Extrusion Capabilities at Somerset Drug Development Center of Excellence

Catalent Expands OptiMelt® Hot Melt Extrusion Capabilities at Somerset Drug Development Center of Excellence SOMERSET, N.J. – April 4, 2019 — Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that it has invested a further $5 million at the company’s […]

Read More

Triphase Accelerator Initiates Phase 1 Clinical Trial of TRPH-222 in B-cell Lymphoma Next Generation Antibody-Drug Conjugate Developed Using Catalent’s SMARTag® ADC Technology

Triphase Accelerator Initiates Phase 1 Clinical Trial of TRPH-222 in B-cell Lymphoma Next Generation Antibody-Drug Conjugate Developed Using Catalent’s SMARTag® ADC Technology Toronto, Ontario, and Somerset, N.J. – April 1, 2019 – Triphase Accelerator Corporation, a company dedicated to acquiring and developing novel therapeutics for the treatment of cancer, and Catalent, the leading global provider […]

Read More

INTUITIVE BIOTECHNOLOGIES OFFERS NOVEL, COST EFFICIENT, AND TIME SAVING ALTERNATIVES TO ANIMAL TESTING FOR THE HEALTHCARE INDUSTRY

PRESS RELEASE DATE: 19March2019 INTUITIVE BIOTECHNOLOGIES OFFERS NOVEL, COST EFFICIENT, AND TIME SAVING ALTERNATIVES TO ANIMAL TESTING FOR THE HEALTHCARE INDUSTRY INTUITIVE BIOTECHNOLOGIES (IBT) is an innovative startup focusing on analytical test-ing of biological samples. It is located at the Pasadena Bio Collaborative Incubator (PBC) in Pasadena, CA. Our company is developing in vitro methodologies […]

Read More

Blog Post by Rapid Novor regarding Mega Pharma Mergers

With the mega pharma mergers that keep cropping up and are likely to continue into the future, what is the impact felt by CROs? What normally happens after merging of two big pharma companies is always a round of laying off and re-organization. Also, the combined pipelines would be trimmed as a result of the […]

Read More

Neox is honored to be recognized in a recent publication by the Czech Society for Athersoclerosis in Athero Review

Neox is honored to be recognized in a recent publication by the Czech Society for Athersoclerosis in Athero Review. Please join us in congratulating all our colleagues who contributed, especially to Jana Maskova. Nutraceuticals with hypolipidemic effect in clinical practice: a summary statement of the International expert panel of lipidologists prepared by the committee of […]

Read More

Catalent Invests Over $27 Million to Commercialize Zydis® Ultra, a Next Generation Oral Disintegrating Tablet

Catalent Invests Over $27 Million to Commercialize Zydis® Ultra, a Next Generation Oral Disintegrating Tablet Catalent SOMERSET, N.J. – March 7, 2019 — Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that it is to invest more than $27 million […]

Read More

Blog by Norac Pharma

• With the mega pharma mergers that keep cropping up and are likely to continue into the future, what is the impact felt by CROs? As a CRO/CMO I would say that this has been a significant factor in the past but less of an issue now. This is clearly summarized in the following article […]

Read More